Monterosa Revenue and Competitors

London, UK

Location

N/A

Total Funding

Media

Industry

Estimated Revenue & Valuation

  • Monterosa's estimated annual revenue is currently $22.6M per year.(i)
  • Monterosa's estimated revenue per employee is $205,000

Employee Data

  • Monterosa has 110 Employees.(i)
  • Monterosa grew their employee count by 5% last year.

Monterosa's People

NameTitleEmail/Phone
1
Co-founder CTOReveal Email/Phone
2
COOReveal Email/Phone
3
CEOReveal Email/Phone
4
Head FinanceReveal Email/Phone
5
Head Solutions DeliveryReveal Email/Phone
6
Head Global Sales - SportsReveal Email/Phone
7
Design DirectorReveal Email/Phone
8
Design Operations ManagerReveal Email/Phone
9
Product ManagerReveal Email/Phone
10
Ecommerce ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.9M590%N/AN/A
#2
$7.4M45-6%N/AN/A
#3
$7.4M45-18%N/AN/A
#4
$401M13689%$2.1MN/A
#5
$3M215%N/AN/A
#6
$152M59379%N/AN/A
#7
$31.8M14124%N/AN/A
#8
$93.3M364-5%N/AN/A
#9
$33.8M150-12%N/AN/A
#10
$46.9M20828%N/AN/A
Add Company

What Is Monterosa?

At Monterosa we love one thing - interactive entertainment. We work in television, sports and beyond, helping to create and power connected entertainment properties that drive massive audiences. Our clients span the globe and include ITV, EA Sports, World Rugby and Nickelodeon. Our apps for shows like Love Island, Got Talent and I'm a Celebrity have hit the #1 spot countless times, serving up billions of interactions for fans every year. Our interaction platform, LViS, makes it easy to deploy ready-made and tailored experiences at scale and on every screen. LViS is the most advanced platform in the business, scaling to millions of users and providing interactivity when it counts.

keywords:N/A

N/A

Total Funding

110

Number of Employees

$22.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Monterosa News

2022-04-20 - Surface Oncology (NASDAQ:SURF) vs. Monte Rosa Therapeutics ...

Surface Oncology (NASDAQ:SURF) vs. Monte Rosa Therapeutics (NASDAQ:GLUE) Financial Review. Posted by admin on Apr 25th, 2022.

2022-04-17 - As El Salvador arrests thousands, families search for the missing

SAN SALVADOR - Gregoria Monterosa steeled herself and walked up to the entrance of the unmarked prison known as El Penalito.

2022-03-22 - Monte Rosa Therapeutics Reports Fourth Quarter and Full Year ...

BOSTON, March 29, 2022 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue...

2020-04-08 - Разработчику, который успел уволиться, выплатили $1000 за отзыв оффера

Диана Васильева Обвал 8 апреля 2020, 09:36 Разработчику, который успел уволиться, выплатили $1000 за отзыв оффера 27 марта фронтенд-разработчик Евгений Савченко уволился из EPAM, так как получил оффер от британской компании Monterosa. А 31 марта узнал, что оффер отозвали — компания «не может ув ...

2019-09-07 - Monte Rosa. Il timelapse del risveglio sotto la neve alla ...

La neve cade da giorni sull'arco alpino, portando ovunque la sensazione che la calda estate 2019 sia ormai un ricordo. Ieri abbiamo ammirato ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16M1105%N/A
#2
$16M110-17%$2.4M
#3
$27.9M11034%N/A
#4
$24.2M11010%N/A
#5
N/A11039%N/A